CTA-PB

E. I. du Pont de Nemours and Company (DuPont) - Q1 2008 10-Q Summary

Business Context and Reporting Period

This Form 10-Q covers the quarterly period ended March 31, 2008. DuPont is a large accelerated filer engaged in the production of agricultural, chemical, and industrial products. The company operates through several segments including Agriculture & Nutrition, Coatings & Color Technologies, Electronic & Communication Technologies, Performance Materials, and Safety & Protection.

Key Financial Metrics

Material Changes vs. Prior Period

• Revenue Growth: Net sales increased 9% year-over-year, driven by a 16% increase in sales outside the U.S. and a 6% increase in local selling prices. U.S. sales remained flat due to a 6% volume decline in construction and automotive markets.
• Profitability: Net income rose 26% to $1.191 billion. This was fueled by revenue growth, fixed cost productivity, a favorable foreign currency impact, and a lower effective tax rate (18.6% vs 27.8%).
• Other Income: Other income, net, decreased $121 million to $195 million, primarily due to a $114 million increase in net pretax exchange losses.
• Cost Structure: Cost of goods sold (COGS) increased 6% but improved as a percentage of sales (69% vs 71%) due to the absence of a prior-year litigation charge and currency benefits, partially offset by higher energy and raw material costs.
• Debt & Liquidity: Total debt increased by $1.7 billion to $9.0 billion to fund seasonal working capital needs, primarily in the Agriculture & Nutrition segment. Operating cash flow turned negative ($951 million used) compared to the prior year, largely due to increased working capital requirements.

Guidance, Outlook, and Risks

• 2008 Outlook: Management projects full-year 2008 earnings in the range of $3.40 to $3.55 per share. This outlook assumes continued revenue growth in emerging markets but accounts for weakness in U.S. construction and North American motor vehicle markets, as well as escalating energy and transportation costs.
• Segment Performance:
  • Agriculture & Nutrition: Sales up 18%, PTOI up 21% (driven by seed sales).
  • Electronic & Communication Technologies: Sales up 12%, PTOI up 41%.
  • Performance Materials: PTOI improved significantly due to the absence of a $52 million litigation charge recorded in Q1 2007.
• Legal & Environmental Contingencies:
  • PFOA: Ongoing environmental actions and litigation regarding perfluorooctanoic acid. Accruals of approximately $0.4 million exist for EPA activities, with a potential $235 million medical monitoring program contingent on scientific panel findings (currently deemed remote).
  • Benlate: Approximately 13 cases remain pending; no remaining accruals as the company believes it will prevail on appeal.
  • Elastomers Antitrust: Provisionally paid a fine of EURO 59.25 ($90.9 million) to the EU; appeal filed. U.S. fine of $84 million is being paid in installments.
  • Spelter, WV: Accrued $55 million following a jury verdict; execution of judgment stayed pending appeal.

Investor Verification Checklist

• Working Capital Seasonality: Verify the sustainability of the $1.7 billion debt increase and the negative operating cash flow, which are attributed to seasonal needs in the Agriculture segment.
• Foreign Exchange Impact: Assess the volatility of net income due to the significant impact of currency fluctuations on both sales (positive) and other income (negative exchange losses).
• Legal Accruals: Monitor the status of the PFOA independent science panel and the outcome of the Spelter, WV appeal, as these could result in material future charges.
• Cost Pass-Through: Evaluate the company's ability to maintain margins given the stated escalation in energy, ingredient, and transportation costs.
• Dividend Continuity: Note the 414th consecutive quarterly dividend of $0.41 per share, indicating a commitment to shareholder returns despite cash flow pressures.